Akanda

35stories

13 Marlast updated

Akanda Sells UK’s Canmart as it Pivots Away From Cannabis, Argent Bio Seeks Deals for Malta Facility, & Chill Brands to Raise £1m

Akanda [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Akanda Corp has become the latest listed cannabis company to announce its (partial) exit from the industry as it pivots from medical cannabis cultivation in Europe to telecommunications in South America.

Ben Stevens13 March 2025

Markets & Stocks

Cantourage Sees Record Profits, Akanda Announced Another Stock Split, & IMC Raises New Funding

14 November 2024

Markets & Stocks

Flora Growth Significantly Expands European Foothold, Akanda Sees Spike in Revenues, & More From Argent Biopharma

31 October 2024

Markets & Stocks

Akanda Implements 2nd Stock Split Amid Debt Woes, DanCann Pharma Earnings Fall Due to Strategy Change, & More From Celadon

23 May 2024

More in Akanda

Markets & Stocks
IMC Stock Jumps Over 60%, Akanda Announces New Strategic Plan, & MGC Becomes Argent BioPharma
IM Cannabis [stock_market_widget type=”chart” template=”line” assets=”IMCC” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] IM Cannabis has seen its share price skyrocket by over 65% this week, despite reporting a 10% decline in revenues and over $10m in net losses in 2023.
Ben Stevens4 Apr
Markets & Stocks
Love Hemp Falls Into Administration for Second Time, Akanda To Issue New Share Offering, & More from Kanabo
Love Hemp The formerly Aquis-listed UK CBD retailer, which collapsed into administration and saw its shares withdrawn in February last year, has called in administrators once again.
Ben Stevens21 Mar
Markets & Stocks
German Cannabis Stocks Spike on CanG Progress, Akanda Offloads Key Sales Generator, & Allied Corp Signs UK Supply Deal
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has seen its share price slip by around 10% this week after it announced plans to sell its Portuguese operations for $2m, seeing it offload a key source of revenue.
Ben Stevens8 Feb
Press releases
Akanda Signs LOI to Sell Portuguese Operations to Somai Pharmaceuticals
Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today announces it has entered into an Amended Non-Binding Letter of Intent (“LOI”)with Somai Pharmaceuticals Ltd. for the sale of RPK, its Portuguese subsidiary.
Ben Stevens2 Feb
Markets & Stocks
Akanda Avoids NASDAQ Delisting, Kanabo to Open Walk-in Clinic, & Hellenic Makes Funding Progress
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has seen its stock rise by around 7% this week as it rode the wave of positive sentiment sending US-listed cannabis stocks skyrocketing.
Ben Stevens18 Jan
Markets & Stocks
Celadon Secures £2M in Funding as It Makes Inaugural Product Delivery, Akanda Appoints New CFO, & Curaleaf Launches on TSX
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Celadon Pharmaceuticals this week passed a ‘significant milestone’ as it completed its first ever supply delivery to clients, just days after the successful completion of a £2m fundraise through a placement of new ordinary shares.
Ben Stevens14 Dec
Markets & Stocks
MGC Pharma In ‘Critical Financial Juncture’ As It Launches Restructuring Plan, Europes First Cannabis ETF To Be Merged As ‘No Longer Viable’, & More From Akanda
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in 2021, informed investors this week that due to adverse market conditions it ‘finds itself at a critical financial juncture’.
Ben Stevens28 Sept
Markets & Stocks
Pharma C Receives £30k Fine For Aquis Rule Breaches, & Akanda Pays Off Halo Loans With Stock
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has settled a loan from its most significant shareholder Halo Collective, with which it shares a CEO, by giving it shares in the company.
Ben Stevens24 Aug

Sections

Data & Trackers

What’s On

More

Akanda

Akanda Sells UK’s Canmart as it Pivots Away From Cannabis, Argent Bio Seeks Deals for Malta Facility, & Chill Brands to Raise £1m

Cantourage Sees Record Profits, Akanda Announced Another Stock Split, & IMC Raises New Funding

Flora Growth Significantly Expands European Foothold, Akanda Sees Spike in Revenues, & More From Argent Biopharma

Akanda Implements 2nd Stock Split Amid Debt Woes, DanCann Pharma Earnings Fall Due to Strategy Change, & More From Celadon

More in Akanda

IMC Stock Jumps Over 60%, Akanda Announces New Strategic Plan, & MGC Becomes Argent BioPharma

Love Hemp Falls Into Administration for Second Time, Akanda To Issue New Share Offering, & More from Kanabo

German Cannabis Stocks Spike on CanG Progress, Akanda Offloads Key Sales Generator, & Allied Corp Signs UK Supply Deal

Akanda Signs LOI to Sell Portuguese Operations to Somai Pharmaceuticals

Akanda Avoids NASDAQ Delisting, Kanabo to Open Walk-in Clinic, & Hellenic Makes Funding Progress

Celadon Secures £2M in Funding as It Makes Inaugural Product Delivery, Akanda Appoints New CFO, & Curaleaf Launches on TSX

MGC Pharma In ‘Critical Financial Juncture’ As It Launches Restructuring Plan, Europes First Cannabis ETF To Be Merged As ‘No Longer Viable’, & More From Akanda

Pharma C Receives £30k Fine For Aquis Rule Breaches, & Akanda Pays Off Halo Loans With Stock